| J9271 | Injection, pembrolizumab, 1 mg | 20,400 | $40 | $877.2K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 70 | $1,110 | $75.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 820 | $60 | $49.2K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 23,680 | $1 | $47.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 500 | $90 | $46.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 460 | $100 | $45K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 120 | $340 | $42K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 470 | $90 | $39.8K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 120 | $270 | $31.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 590 | $50 | $27.9K |